Skip to main content
PolyPid Ltd. logo

PolyPid Ltd. — Investor Relations & Filings

Ticker · PYPD ISIN · IL0011326795 US Manufacturing
Filings indexed 225 across all filing types
Latest filing 2025-12-16 Foreign Filer Report
Country US United States of America
Listing US PYPD

About PolyPid Ltd.

https://www.polypid.com

PolyPid Ltd. is a clinical-stage biopharmaceutical company focused on developing locally administered, prolonged-release therapeutics to improve surgical outcomes. The company's proprietary PLEX™ (Polymer-Lipid Encapsulation) drug delivery platform is designed to provide a controlled and extended release of medications directly at the target site. Its lead product candidate, D-PLEX₁₀₀, is in late-stage development for the prevention of surgical site infections (SSIs). PolyPid is also leveraging its PLEX platform to develop a pipeline of new treatments, including a long-acting delivery system for GLP-1 receptor agonists for the diabetes and weight loss market.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-12-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-12-03 English
PROSPECTUS SUPPLEMENT
Prospectus
2025-11-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-11-26 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.